dc.contributor.author |
Phungphong S. |
|
dc.contributor.author |
Kijtawornrat A. |
|
dc.contributor.author |
de Tombe P.P. |
|
dc.contributor.author |
Wattanapermpool J. |
|
dc.contributor.author |
Bupha-Intr T. |
|
dc.contributor.author |
Suksamrarn S. |
|
dc.date.accessioned |
2021-04-05T03:22:01Z |
|
dc.date.available |
2021-04-05T03:22:01Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
10956670 |
|
dc.identifier.other |
2-s2.0-85020256751 |
|
dc.identifier.uri |
https://ir.swu.ac.th/jspui/handle/123456789/13021 |
|
dc.identifier.uri |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020256751&doi=10.1002%2fjbt.21942&partnerID=40&md5=09ca837c52a5416a4bc27861793e15e0 |
|
dc.description.abstract |
The benefits of α-mangostin for various tissues have been reported, but its effect on the heart has not been clarified. This study aimed to evaluate the effects of α-mangostin on cardiac function. Using a cardiac sarcoplasmic reticulum (SR) membrane preparation, α-mangostin inhibited SR Ca2+-ATPase activity in a dose-dependent manner (IC50 of 6.47 ± 0.7 μM). Its suppressive effect was specific to SR Ca2+-ATPase but not to myofibrillar Ca2+-ATPase. Using isolated cardiomyocytes, 50 μM of α-mangostin significantly increased the duration of cell relengthening and increased the duration of Ca2+ transient decay, suggesting altered myocyte relaxation. The relaxation effect of α-mangostin was also supported in vivo after intravenous infusion. A significant suppression of both peak pressure and rate of ventricular relaxation (–dP/dt) relative to DMSO infusion was observed. The results from the present study demonstrated that α-mangostin exerts specific inhibitory action on SR Ca2+-ATPase activity, leading to myocardial relaxation dysfunction. © 2017 Wiley Periodicals, Inc. |
|
dc.subject |
adenosine triphosphatase (calcium) |
|
dc.subject |
adenosine triphosphatase (magnesium) |
|
dc.subject |
alpha mangostin |
|
dc.subject |
calcium ion |
|
dc.subject |
dimethyl sulfoxide |
|
dc.subject |
sarcoplasmic reticulum calcium transporting adenosine triphosphatase |
|
dc.subject |
unclassified drug |
|
dc.subject |
xanthone derivative |
|
dc.subject |
mangostin |
|
dc.subject |
sarcoplasmic reticulum calcium transporting adenosine triphosphatase |
|
dc.subject |
xanthone derivative |
|
dc.subject |
adult |
|
dc.subject |
animal cell |
|
dc.subject |
animal experiment |
|
dc.subject |
animal tissue |
|
dc.subject |
Article |
|
dc.subject |
cardiac muscle cell |
|
dc.subject |
cell isolation |
|
dc.subject |
concentration response |
|
dc.subject |
dose response |
|
dc.subject |
drug dose comparison |
|
dc.subject |
drug specificity |
|
dc.subject |
enzyme inhibition |
|
dc.subject |
heart left ventricle pressure |
|
dc.subject |
heart left ventricle relaxation |
|
dc.subject |
heart muscle relaxation |
|
dc.subject |
in vitro study |
|
dc.subject |
in vivo study |
|
dc.subject |
male |
|
dc.subject |
nonhuman |
|
dc.subject |
rat |
|
dc.subject |
animal |
|
dc.subject |
antagonists and inhibitors |
|
dc.subject |
cardiac muscle |
|
dc.subject |
diastole |
|
dc.subject |
drug effects |
|
dc.subject |
heart ventricle |
|
dc.subject |
Leporidae |
|
dc.subject |
metabolism |
|
dc.subject |
pathophysiology |
|
dc.subject |
Animals |
|
dc.subject |
Diastole |
|
dc.subject |
Heart Ventricles |
|
dc.subject |
Male |
|
dc.subject |
Myocardium |
|
dc.subject |
Myocytes, Cardiac |
|
dc.subject |
Rabbits |
|
dc.subject |
Sarcoplasmic Reticulum Calcium-Transporting ATPases |
|
dc.subject |
Xanthones |
|
dc.title |
Acute inhibitory effect of alpha-mangostin on sarcoplasmic reticulum calcium-ATPase and myocardial relaxation |
|
dc.type |
Article |
|
dc.rights.holder |
Scopus |
|
dc.identifier.bibliograpycitation |
Journal of Biochemical and Molecular Toxicology. Vol 31, No.10 (2017) |
|
dc.identifier.doi |
10.1002/jbt.21942 |
|